Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning

Inogen (NSDQ:INGN) this week announced it appointed Agnes Lee as senior VP of investor relations and strategic planning, effective May 23.

Lee most recently served as VP of investor relations at Butterfly Network where she created an investor relations program to promote the company to analysts and investors. She also led investor marketing to reflect an evolution of the company’s vision and strategy.

“I am excited to welcome Agnes to the Inogen team as we continue to strengthen our strategic planning capabilities, further execute against our growth initiatives and communicate our strategy internally and externally, all with the overarching goal of transforming Inogen and driving shareholder value. Agnes brings extensive medical technology and life sciences experience and has an excellent track record in effective engagement with shareholders and analysts,” CEO Nabil Shabshab said in a news release.

Lee has held numerous leadership roles at Fluidig…

Read more
  • 0

Inogen rises despite missed Q4 projections

Inogen (NSDQ:INGN) shares ticked up today on fourth-quarter results that came up shy of the consensus forecast.

INGN shares were up 6.9% at $32.01 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.1%.

The Goleta, California-based company posted losses of $22.9 million, or $1.01 per share, on sales of $76.4 million for the three months ended Dec. 31, 2021, for a large bottom-line slide deeper into the red on sales growth of 3.3%.

Inogen’s losses per share of $1.01 came in 30¢ behind projections on Wall Street, where analysts were looking for sales of $76.6 million.

“Over the past year, our team has made steady progress to advance our overall strategy, working to expand our sales footprint in the prescriber channel and implement initiatives aimed at driving productivity of our overall commercial operations,” Inogen President and …

Read more
  • 0

Inogen CFO stepping down, interim replacement named

Inogen (NSDQ:INGN) announced today that it appointed Mike Sergesketter as its interim chief financial officer.

Goleta, California-based Inogen said in a news release that Sergesketter — whose role as CFO was made effective today — most recently served as CFO of Kimball Electronics.

Sergesketter success Alison Bauerlein, who will remain on with Inogen in a transitional finance role through the first quarter of 2022. The company has enlisted an executive search firm to help with the hunt for a permanent replacement.

“I am grateful for the time and collaboration I have had with Ali and want to thank her for her many contributions as a key member of the team that launched and grew Inogen,” Inogen President & CEO Nabil Shabshab said in the release. “I wish her well in her future endeavors.”

Sergesketter has over 40 years of finance experience in the manufacturing services industry, having led the transformation of the finance and …

Read more
  • 0

Inogen names chief technology officer

Inogen (NSDQ:INGN) this week announced that it has appointed Stanislav Glezer as chief technology officer.

Glezer will be responsible for R&D and engineering, medical affairs and regulatory affairs. He joined the company in June this year as chief medical officer and will remain an executive VP of the company.

Prior to joining the company, Glezer held numerous leadership roles at medical technology and biotechnology firms like BD, Adocia, Novo Nordisk and Sanofi.

Goleta, California-based Inogen also said that executive VP of engineering Brenton Taylor will leave the company following a transition period ending April 1, 2022.

“Since joining Inogen as chief medical officer earlier this year, Stan has made a significant impact in helping us instill clinically-informed discipline in innovation, product development practices and go-to-market strategy. In this new role, Stan’s deep background in clinical research, success in developing, commercializ…

Read more
  • 0

MedTech 100 roundup: Significant uptick for industry

The up-and-down nature of the medtech industry continues to carry through 2021, with a recent dip now followed by a rapid ascent.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 11) at 109.63 points, producing a 2.5% rise from the 106.96-point mark set one week prior (June 4).

It provides a welcome sight after the industry’s progress came to a halt with a -1.4% dip the week before last. The index remains in a position to produce another upswing after demonstrating signs of picking up again when April brought the industry’s all-time best performance.

Even with setbacks that slowed the industry recently, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 18.8% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus a 76.5% increase from the mid-pandemic low…

Read more
  • 0

Inogen appoints chief medical officer

Inogen (NSDQ:INGN) this week announced that it has appointed Stanislav Glezer as executive VP and chief medical officer, effective June 21.

Glezer joins the Goleta, Calif.-based company after a stint as worldwide VP of medical care for diabetes care at BD. Prior to BD, he served as chief medical officer at Adocia and has held numerous leadership roles within Novo Nordisk and Sanofi.

“On behalf of the board of directors, I would like to congratulate Stan on this appointment as I am confident that he will be a tremendous asset to Inogen and a great addition to our executive team. I believe that expanding our clinical expertise and evidence dossier in respiratory therapy will serve us well in our endeavors to drive our market development efforts to eventually increase the penetration of portable oxygen concentrators (POCs) in support of our growth strategy as well as help guide our innovation agenda,” CEO Nabil Shabshab said in a news release. “I belie…

Read more
  • 0

Inogen beats Wall Street EPS consensus by 22¢ in Q1 results

Inogen (NSDQ:INGN) posted first-quarter results yesterday that beat the overall consensus on Wall Street.

The Goleta, Calif.-based company reported losses of -$732,000, or -3¢ per share, on sales of $86.932 million for the three months ended March 31, for a sales loss of -1.76% compared with Q1 2020.

Earnings per share were -3¢, 22¢ ahead of The Street, where analysts were looking for sales of $79.39 million.

“While the COVID-19 pandemic continued to have an impact on our business in the first quarter of 2021, we saw sequential growth in all four channels, and sequential growth of 17.5% in total revenue for the reported quarter,” president and CEO Nabil Shabshab said in a news release. “Additionally, our focus on the rental channel continues to produce strong operating performance with rental revenue growing significantly in the first quarter of 2021 versus the comparable period in the prior year. We continue to be focused on creating long-term value by …

Read more
  • 0

Inogen names former BD exec as chief commercial officer

Inogen (NSDQ:INGN) announced today that its board of directors appointed George Parr as its EVP and chief commercial officer.

Goleta, Calif.-based Inogen’s EVP of marketing, Byron Myers, and EVP of sales, Arron Retterer, announced earlier this month that they plan to leave Inogen, effective June 4, 2021, following a transition period. Parr will assume his role, effective April 12, 2021, according to a news release.

Parr most recently served as EVP & CMO at BD, holding the role from November 2017 through January 2020. He also served as SVP & CMO at SIRVA Worldwide Relocating & Moving from 2014 to 2017 and before that he held the role of SVP & CMO at Diversey.

“I am honored by the opportunity to lead the commercial operations of Inogen in our mission to increase the freedom and independence for respiratory patients and to make our technologies the standard of care,” Parr said in the release. “I look forward to contributing to the next…

Read more
  • 0

Inogen names new CEO

Inogen (NSDQ:INGN) announced that it appointed Nabil Shabshab to serve as its new CEO, effective on Feb. 8, 2021.

Additionally, according to a news release, on Jan. 22, Inogen’s board appointed Shabshab to serve as a Class II director of the company, effective Feb. 8, too. His term will expire at the annual meeting of stockholders to be held in 2022.

Shabshab is set to succeed former CEO Scott Wilkinson, who announced his upcoming retirement as president, CEO and director in June. Wilkinson’s retirement is effective Feb. 8.

A veteran of the industry, Shabshab most recently served as worldwide president of diabetes care & digital health at Becton Dickinson since August 2017. Before that, from 2011, he was BD’s chief marketing officer and executive VP of strategic planning.

Prior to BD, Shabshab was executive VP, global portfolio, chief marketing officer and head of RD&E at Diversey, a cleaning…

Read more
  • 0

Inogen CEO announces retirement, commences successor search

Inogen CEO and president Scott Wilkinson announced his intention to retire from both of his positions and as a member of the Board of Directors before the end of next year.

Wilkinson plans to remain in his current position until his successor is appointed while assisting the board in the search for his replacement.

“On behalf of the board, I want to thank Scott for his significant contributions and dedicated years of service to Inogen,” chairperson of the board Heath Lukatch said in a news release. “Scott’s leadership and industry expertise will be missed by Inogen, and we are extremely thankful for his many contributions during his tenure. The board and management team are committed to ensuring a smooth transition, and we are grateful that we’ll continue to benefit from Scott’s experience and perspective throughout this process.”

Inogen said it has initiated a process to identify Wilkinson’s replacement and intends to engage an executive sea…

Read more
  • 0